March 02, 2015 2:37 PM ET

Pharmaceuticals

Company Overview of TargeGen Inc.

Company Overview

TargeGen Inc. is a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target vascular leakage (edema), vascular proliferation (angiogenesis), and inflammation. The company offers its products for the treatment of human diseases, such as heart attack, cancer, and eye diseases; vascular leakage, edema, and the unwanted growth of new blood vessels; pleural effusions, arthritis, pulmonary edema, transplant ischemia, ARDS, brain inflammation, hypovolemia (acute blood loss) CNS disorders, and other serious medical conditions. It serves macular degeneration, diabetic macular edema, and diabetic retinopathy markets. The company was founde...

9380 Judicial Drive

San Diego, CA 92121

United States

Founded in 2002

Phone:

858-678-0760

Fax:

858-678-0762

Key Executives for TargeGen Inc.

Chief Financial Officer and Vice President of Finance
Vice President of Clinical Development
Vice President of Regulatory Affairs & Drug Development
Age: 66
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Procare Rx, Inc. United States
Centrix Pharmaceutical, Inc. United States
OrPro Therapeutics, Inc. United States
InB: Hauser Pharmaceutical Services, Inc. United States
Zengen Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TargeGen Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.